SIGN UP
LOG IN
M
MRSN
Mersana Therapeutics Inc
0.40
0.00-0.58%After Hours: 0.3989 +0.0012 +0.30%19:29 05/02 EDT
OPEN/PREV CLOSE0.4067/0.4000
TODAY RANGE0.3751-0.4099
VOL1.57M
MARKET CAP49.57M
52 WEEK RANGE0.2589-3.630
AVG VOL (3M)3.49M
% TURNOVER1.26%
TURNOVER--
P/E (TTM)-0.7043
% RANGE8.58%
EPS(TTM)-0.5647
P/E(FORWARD)-0.5233
P/B-4.8382
BVPS-0.0822
DIVIDEND--
P/S1.136
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP48.82M
SHARES OUTSTANDING124.63M
NEXT EARNINGS05/07-05/12
FREE FLOAT122.75M
LOT SIZE1
EX-DIV DATE--
News
Press Releases
Financial Reports
Profile
Simply Wall St·03/27 10:32
Mersana Therapeutics, Inc. (NASDAQ:MRSN) Looks Inexpensive After Falling 26% But Perhaps Not Attractive Enough
Simply Wall St·03/08 12:58
Industry Analysts Just Made A Meaningful Upgrade To Their Mersana Therapeutics, Inc. (NASDAQ:MRSN) Revenue Forecasts
TipRanks·03/04 12:38
Truist Financial Reaffirms Their Buy Rating on Mersana Therapeutics (MRSN)
Simply Wall St·03/04 11:07
Mersana Therapeutics Full Year 2024 Earnings: Beats Expectations
TipRanks·03/04 03:55
Mersana Therapeutics Reports Progress and Financial Results
Press release·03/03 20:55
Mersana Therapeutics, Inc. Reports 2024 Annual Results
Same Industry
Name/Symbol
Change%
Price
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.